Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine M Cross

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Organic & Biomolecular Chemistry|October 27, 2017
Perfluorinated HDAC inhibitors as selective anticancer agentsJames W Walton, Jasmine M Cross, Tina Riedel, et al.
Chempluschem|January 23, 2020
Anticancer Ru<sup>II</sup> and Rh<sup>III</sup> Piano-Stool Complexes that are Histone Deacetylase InhibitorsJasmine M Cross, Tim R Blower, Natalie Gallagher, et al.
Chemical Communications (Cambridge, England)|October 25, 2013
Self-assembly of a heteroleptic one-dimensional chain comprising different dinuclear meso-helicates in the solid-stateJasmine M Cross, Rebecca V Fennessy, Lindsay P Harding, et al.
Chemical Communications (Cambridge, England)|July 30, 2013
Steric control of the formation of dinuclear double helicate and dinuclear meso-helicate assembliesDavid J Cooke, Jasmine M Cross, Rebecca V Fennessy, et al.
Molecules (Basel, Switzerland)|May 28, 2020
Anticancer Ruthenium Complexes with HDAC Isoform SelectivityJasmine M Cross, Tim R Blower, Alexander D H Kingdon, et al.
RSC Medicinal Chemistry|December 22, 2022
A 'click' chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimerasJasmine M Cross, Megan E Coulson, Joshua P Smalley, et al.
Dalton Transactions (Cambridge, England : 2003)|July 29, 2016
Pyridylphosphinate metal complexes: synthesis, structural characterisation and biological activityJasmine M Cross, Natalie Gallagher, Jason H Gill, et al.
RSC Medicinal Chemistry|January 13, 2022
Correction: Truncated S-MGBs: towards a parasite-specific and low aggregation chemotypeDaniel P Brooke, Leah M C McGee, Federica Giordani, et al.
RSC Medicinal Chemistry|August 27, 2021
Truncated S-MGBs: towards a parasite-specific and low aggregation chemotypeDaniel P Brooke, Leah M C McGee, Federica Giordani, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2022
Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infectionNathan S Kieswetter, Mumin Ozturk, Lerato Hlaka, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Organic & Biomolecular Chemistry|October 27, 2017
Perfluorinated HDAC inhibitors as selective anticancer agentsJames W Walton, Jasmine M Cross, Tina Riedel, et al.
Chempluschem|January 23, 2020
Anticancer Ru<sup>II</sup> and Rh<sup>III</sup> Piano-Stool Complexes that are Histone Deacetylase InhibitorsJasmine M Cross, Tim R Blower, Natalie Gallagher, et al.
Chemical Communications (Cambridge, England)|October 25, 2013
Self-assembly of a heteroleptic one-dimensional chain comprising different dinuclear meso-helicates in the solid-stateJasmine M Cross, Rebecca V Fennessy, Lindsay P Harding, et al.
Chemical Communications (Cambridge, England)|July 30, 2013
Steric control of the formation of dinuclear double helicate and dinuclear meso-helicate assembliesDavid J Cooke, Jasmine M Cross, Rebecca V Fennessy, et al.
Molecules (Basel, Switzerland)|May 28, 2020
Anticancer Ruthenium Complexes with HDAC Isoform SelectivityJasmine M Cross, Tim R Blower, Alexander D H Kingdon, et al.
RSC Medicinal Chemistry|December 22, 2022
A 'click' chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimerasJasmine M Cross, Megan E Coulson, Joshua P Smalley, et al.
Dalton Transactions (Cambridge, England : 2003)|July 29, 2016
Pyridylphosphinate metal complexes: synthesis, structural characterisation and biological activityJasmine M Cross, Natalie Gallagher, Jason H Gill, et al.
RSC Medicinal Chemistry|January 13, 2022
Correction: Truncated S-MGBs: towards a parasite-specific and low aggregation chemotypeDaniel P Brooke, Leah M C McGee, Federica Giordani, et al.
RSC Medicinal Chemistry|August 27, 2021
Truncated S-MGBs: towards a parasite-specific and low aggregation chemotypeDaniel P Brooke, Leah M C McGee, Federica Giordani, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2022
Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infectionNathan S Kieswetter, Mumin Ozturk, Lerato Hlaka, et al.
Pageof 1